Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
PTI

DGCI gives nod to SII’s proposal to manufacture vaccine against omicron for test, analysis

Photo used for representation purpose only.

The Drugs Controller General of India (DCGI) has approved Serum Institute of India’s proposal to manufacture a vaccine against omicron variant of coronavirus for examination, test and analysis, official sources said on Monday.

“With reference to your application, please find herewith the permission to manufacture SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein nanoparticle vaccine (omicron variant) for examination, test and analysis under the provisions of New Drugs and Clinical Trials Rules, 2019 to manufacture the test batches of the drug/drugs mentioned therein,” an approval order issued on February 4 stated.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.